SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Comparing pharmaceutical pricing and reimbursement policies in Croatia to the European Union Member States
16 references·0 citing·36 second hop
Comparing pharmaceutical pricing and reimbursement policies in Croatia to the European Union Member States (2011)Comparing pharmaceutical pricing and reim…THE WORLD MEDICINES SITUATION 2011 (2011)THE WORLD MEDICINES SITUATION…Impact of European Pharmaceutical Price Regulation on Generic Price Competition (2010)Impact of European Pharmaceut…The Effect Of Regulation On Pharmaceutical Revenues: Experience In Nineteen Countries (2008)The Effect Of Regulation On P…Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis (2008)Medicine prices, availability…Ensuring value for money in health care: the role of health technology assessment in the European Union (2008)Ensuring value for money in h…Sustaining Generic Medicines Markets in Europe (2006)Sustaining Generic Medicines …Is access to essential medicines as part of the fulfilment of the right to health enforceable through the courts? (2006)Is access to essential medici…Essential medicines and human rights: what can they learn from each other? (2006)Essential medicines and human…Regulating Pharmaceuticals in Europe: Striving for Efficiency, Equity and Quality (2005)Regulating Pharmaceuticals in…The impact of price regulation on the launch delay of new drugs—evidence from twenty‐five major markets in the 1990s (2004)The impact of price regulatio…The concept of essential medicines: lessons for rich countries (2004)The concept of essential medi…Regulating pharmaceuticals in Europe : striving for efficiency, equity and quality (2004)Regulating pharmaceuticals in…Encouraging the use of generic medicines: implications for transition economies. (2002)Encouraging the use of generi…Cross-national price differences for pharmaceuticals: how large, and why? (2000)Cross-national price differen…International Price Comparisons for Pharmaceuticals (1998)International Price Compariso…The role of economic evaluation in the pricing and reimbursement of medicines (1997)The role of economic evaluati…The economics of moral hazard: comment (1982)The price of innovation: new estimates of drug development costs (2003)UNCERTAINTY AND THE WELFARE ECONOMICS OF MEDICAL CARE (2003)Competition in off-patent drug markets: Issues, regulation and evidence (2008)What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries (2008)Pharmaceutical policies in European countries in response to the global financial crisis (2011)Review of the literature on reference pricing (2000)Policies to promote use of generic medicines in low and middle income countries: A review of published literature, 2000–2010 (2012)Switching from Originator Brand Medicines to Generic Equivalents in Selected Developing Countries: How Much Could Be Saved? (2012)A National Survey of the Arrangements Managed-Care Plans Make with Physicians (1995)Ten recommendations to improve use of medicines in developing countries (2001)The selection and use of essential medicines. (2004)Making medicines essential: The emergent centrality of pharmaceuticals in global health (2011)Male-Female Wage Differentials in Urban Labor Markets (1973)Labor Market Discrimination Against Hispanic and Black Men (1983)Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug Act (1992)Does Regulation Drive Out Competition in Pharmaceutical Markets? (2000)The Hedonic Method (2003)Parallel imports and the pricing of pharmaceutical products: evidence from the European Union (2004)Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study (1997)World Population Prospects The 2006 Revision (2007)How to improve R&D productivity: the pharmaceutical industry's grand challenge (2010)Access to medicines from a health system perspective (2012)Access to Medications for Cardiovascular Diseases in Low- and Middle-Income Countries (2016)The path to longer and healthier lives for all Africans by 2030: the Lancet Commission on the future of health in sub-Saharan Africa (2017)An Evaluation of Consumer Protection Legislation: The 1962 Drug Amendments (1973)Differential Pricing for Pharmaceuticals: Reconciling Access, R&D and Patents (2003)Pharmaceutical Price Controls and Entry Strategies (2007)Market size and pharmaceutical innovation (2015)Pharmaceutical policies: effects of financial incentives for prescribers (2015)History, principles, and practice of health and human rights (2007)The judicialization of biopolitics: Claiming the right to pharmaceuticals in Brazilian courts (2013)Physician Agency and Adoption of Generic Pharmaceuticals (2012)The experiences of implementing generic medicine policy in eight countries: A review and recommendations for a successful promotion of generic medicine use (2013)The Economic Costs of Type 2 Diabetes: A Global Systematic Review (2015)Essential medicines for universal health coverage (2016)
this work references cited by second hop

References

  • 2008Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis926 cited
  • 2011THE WORLD MEDICINES SITUATION 2011427 cited
  • 2004The impact of price regulation on the launch delay of new drugs—evidence from twenty‐five major markets in the 1990s344 cited
  • 2000Cross-national price differences for pharmaceuticals: how large, and why?285 cited
  • 2006Is access to essential medicines as part of the fulfilment of the right to health enforceable through the courts?253 cited
  • 2002Encouraging the use of generic medicines: implications for transition economies.188 cited
  • 2004Regulating pharmaceuticals in Europe : striving for efficiency, equity and quality162 cited
  • 2006Sustaining Generic Medicines Markets in Europe161 cited
  • 2004The concept of essential medicines: lessons for rich countries157 cited
  • 2005Regulating Pharmaceuticals in Europe: Striving for Efficiency, Equity and Quality155 cited
  • 2006Essential medicines and human rights: what can they learn from each other?152 cited
  • 1997The role of economic evaluation in the pricing and reimbursement of medicines130 cited
  • 2008Ensuring value for money in health care: the role of health technology assessment in the European Union120 cited
  • 2010Impact of European Pharmaceutical Price Regulation on Generic Price Competition

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

114 cited
  • 2008The Effect Of Regulation On Pharmaceutical Revenues: Experience In Nineteen Countries85 cited
  • 1998International Price Comparisons for Pharmaceuticals78 cited
  • Cited by

    No citing works inside the corpus for this window.